Joseph Zabell
Papers
2
Total Citations
9
H-Index
1
About
Dr. Joseph Zabell is a urologic surgeon and researcher whose work centers on improving surgical outcomes for patients with bladder cancer, particularly those undergoing radical cystectomy. His primary research focus is the optimization of perioperative care through Enhanced Recovery After Surgery (ERAS) protocols. Dr. Zabell’s most significant contribution is demonstrating that the inclusion of alvimopan—a peripherally acting mu-opioid receptor antagonist—as a core component of ERAS pathways significantly reduces postoperative ileus and shortens hospital stays. His landmark 2021 study, with 8 citations, analyzed 296 consecutive patients and provided compelling evidence that this combined approach is both safe and effective for decreasing length of stay without increasing complications. This work has helped establish alvimopan as an essential, rather than optional, element of modern ERAS protocols in urologic oncology. By translating pharmacological advances into practical, evidence-based clinical pathways, Dr. Zabell has directly contributed to faster recovery, reduced healthcare costs, and improved patient quality of life after major cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2